Search research articles
Contact Us
Filters
Showing results (851-860 of 873) with videos related to
Page
of 88
Sort By:
Gynecologic Oncology
|
May 21, 2019
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy
Karen M Gil, Stephanie L Pugh, Ann H Klopp, et al.
JCO Oncology Advances
|
May 15, 2025
Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203
Kelsey L Corrigan, Rebecca Paulus, Ann H Klopp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2020
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study
Anamaria R Yeung, Stephanie L Pugh, Ann H Klopp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203
Ann H Klopp, Anamaria R Yeung, Snehal Deshmukh, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 29, 2020
Management of meningeal solitary fibrous tumors/hemangiopericytoma; surgery alone or surgery plus postoperative radiotherapy?
R L Haas, I Walraven, E Lecointe-Artzner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2022
Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial
Anamaria R Yeung, Snehal Deshmukh, Ann H Klopp, et al.
Cancers
|
December 28, 2019
Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models
Maria Anna Smolle, Michiel van de Sande, Dario Callegaro, et al.
The Lancet. Oncology
|
September 17, 2020
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
Sylvie Bonvalot, Alessandro Gronchi, Cécile Le Péchoux, et al.
Cancer Immunology, Immunotherapy : CII
|
July 2, 2025
Divergent therapeutic and prognostic impacts of immunogenic features in undifferentiated pleomorphic sarcoma and myxofibrosarcoma
Siddh van Oost, Debora M Meijer, Zeynep B Erdem, et al.
The New England Journal of Medicine
|
August 18, 2021
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
Frederick K Korley, Valerie Durkalski-Mauldin, Sharon D Yeatts, et al.
Page
of 88
Search research articles
Search
Showing results (851-860 of 873) with videos related to
Sort By:
Page
of 88
Gynecologic Oncology
|
May 21, 2019
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy
Karen M Gil, Stephanie L Pugh, Ann H Klopp, et al.
JCO Oncology Advances
|
May 15, 2025
Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203
Kelsey L Corrigan, Rebecca Paulus, Ann H Klopp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2020
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study
Anamaria R Yeung, Stephanie L Pugh, Ann H Klopp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203
Ann H Klopp, Anamaria R Yeung, Snehal Deshmukh, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 29, 2020
Management of meningeal solitary fibrous tumors/hemangiopericytoma; surgery alone or surgery plus postoperative radiotherapy?
R L Haas, I Walraven, E Lecointe-Artzner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2022
Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial
Anamaria R Yeung, Snehal Deshmukh, Ann H Klopp, et al.
Cancers
|
December 28, 2019
Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models
Maria Anna Smolle, Michiel van de Sande, Dario Callegaro, et al.
The Lancet. Oncology
|
September 17, 2020
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
Sylvie Bonvalot, Alessandro Gronchi, Cécile Le Péchoux, et al.
Cancer Immunology, Immunotherapy : CII
|
July 2, 2025
Divergent therapeutic and prognostic impacts of immunogenic features in undifferentiated pleomorphic sarcoma and myxofibrosarcoma
Siddh van Oost, Debora M Meijer, Zeynep B Erdem, et al.
The New England Journal of Medicine
|
August 18, 2021
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
Frederick K Korley, Valerie Durkalski-Mauldin, Sharon D Yeatts, et al.
Page
of 88